Companies: 10,795·Total market cap: $144.5T
Myriad Genetics, Inc.

Myriad Genetics, Inc.

MYGNNASDAQHealthcare● Active
$4.39
$-0.18(-3.94%)
Market Cap$414627598
P/E Ratio
52W High$8.59
52W Low$3.53
Overview

Myriad Genetics, Inc. (MYGN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MYGN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.30mygn eps ttm · mygn earnings per shareEarnings history
PE Ratio (TTM)mygn pe ratio ttm · mygn price to earningsPE Ratio deep dive
Revenue (TTM)$829.0Mmygn revenue ttm · mygn annual revenueFull revenue history
Dividend Yield13.45%does mygn pay dividends · mygn dividend yieldDividend history
Shares Outstanding93.3Mmygn shares outstanding · mygn floatShares outstanding history
Next EarningsAug 4, 2026Est.mygn earnings date · mygn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$824.5M▼ 1.56% YoY
202320242025
myriad genetics, inc. revenue · mygn revenue 2025
FY 2025Net Income-$365.9M▼ 187.43% YoY
202320242025
myriad genetics, inc. net income · mygn profit 2025
FY 2025EPS$-3.96▼ 180.85% YoY
202320242025
mygn eps · myriad genetics, inc. earnings per share 2025
TTM:Revenue: $829.0MNet Income: -$399.9MEPS: $-4.30View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold36 analystsis mygn a buy · mygn analyst rating
Strong Buy
0
Buy
8
Hold
22
Sell
6
Strong Sell
0
12-Month Price Target
$6.00Low
$4.39Current
$6.00Avg Target36.67% upside
$6.00High
mygn price target · mygn 12 month forecast

Total: 36 · Buy rate: 22.2%

The MYGN analyst consensus is Hold, based on ratings from 36 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +36.67% upside from the current price of $4.39.

Stock Performance

Full History
1D-2.63%
1W+3.97%
1M+3.73%
3M-13.59%
YTD-27.64%
1Y-14.26%
5Y-85.07%

About Myriad Genetics, Inc.

CEOSamraat S. Raha
IPO DateOct 6, 1995
Employees2,700
CountryUS
Websitemyriad.com

Myriad Genetics, Inc. is a leading company specializing in genetic testing and precision medicine. The firm focuses on developing and marketing a wide array of genetic diagnostic solutions across both…

what is myriad genetics, inc. · mygn stock overview · myriad genetics, inc. company profile · who is myriad genetics, inc. ceo · mygn NASDAQ · myriad genetics, inc. headquarters · myriad genetics, inc. business segments

About Stock Overview & Key Data

Myriad Genetics, Inc. (MYGN) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Oct 6, 1995. As of the latest trading session, MYGN stock price is $4.39, with a market capitalization of $414.6M. The stock has returned -14.26% over the past 12 months and -27.64% year-to-date.

According to 36 Wall Street analysts, the consensus rating for Myriad Genetics, Inc. stock is Hold, with an average 12-month price target of $6.00. In fiscal year 2025, Myriad Genetics, Inc. reported revenue of $824.5M and net income of -$365.9M. For detailed data — including Myriad Genetics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Myriad Genetics, Inc. (MYGN) stock price is $4.39. The stock is traded on NASDAQ under the ticker symbol MYGN. The 52-week range is $3.53 – $8.59.

MYGN stock priceMYGN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice